top of page

Cyprus DIASPORA 2025

Dimitris Kyriakou demonstrating VITALE at Cyprus DIASPORA

The recent Cyprus Diaspora Forum, demonstrated its value as a pivotal gathering for the global Cypriot community, bringing together influential diaspora members, business leaders, innovators, and investors. One of the standout moments of this year’s event was the participation of Dr. Dimitris Kyriakou, CEO and co-founder of EFEVRE TECH, who took the stage to present VITALE—a groundbreaking software set to revolutionize the landscape of scientific research.


Demonstrating VITALE: The Vision Behind VITALE

VITALE software is not just another software; it represents a holistic digitalization tool designed for life-science research. It aims to automate laboratory experiments, digitally document research progress and results, and enable unbiased analysis of scientific outcomes. By providing reliable and reproducible results, the proposed VITALE software project is set to challenge the global research methodologies that have remained static for decades.

During his presentation, Dr. Kyriakou passionately outlined how VITALE addresses some of the most pressing challenges faced by researchers today. From handling vast datasets to ensuring consistency and accuracy, VITALE integrates cutting-edge AI-driven analytics to optimize the scientific workflow. The software’s ability to maintain data integrity while accelerating the research process received enthusiastic responses from the audience.

Dr. Kyriakou used the opportunity to emphasize the role of VITALE in promoting transparent, replicable, and accurate scientific findings. In a world increasingly driven by data, VITALE's approach to managing laboratory information and providing actionable insights stands out as an invaluable tool for research institutions worldwide. Moreover, he highlighted the platform’s potential for fostering collaboration across diverse scientific disciplines.


Strategic Value: A Global Perspective

The Cyprus DIASPORA Forum, known for attracting high-net-worth individuals, prominent business professionals, and members of the Cypriot DIASPORA, served as the ideal platform for EFEVRE TECH to showcase VITALE. The event not only provided a stage to introduce the software to a global audience but also opened doors to potential collaborations with investors and scientific communities eager to embrace innovation.


Targeted Strategic Meetings and Opportunities

During the DIASPORA 2025 event, EFEVRE TECH actively engaged in high-value strategic discussions with influential players across consulting, pharmaceuticals, and healthcare innovation:

  • Remedica Ltd: A leading pharmaceutical manufacturer in Cyprus, Remedica expressed strong interest in our lab automation technologies. Following the event, a direct communication channel was established with their R&D division to explore potential co-development projects. Our proposal centered on combining Remedica’s pharmaceutical insight with our robotics and AI expertise to co-finance and co-develop next-generation automation solutions for global commercialization.

  • HealthManagement.org: EFEVRE TECH was invited by Christian Marolt, Executive Director, to contribute a dedicated thought leadership article to their international platform. This opens visibility to over 40,000 stakeholders spanning C-suite executives, clinicians, and IT decision-makers. The collaboration positions VITALE at the intersection of laboratory automation and health innovation leadership.

  • Deloitte Cyprus: Through discussions with their Financial Advisory Services team, we explored strategic funding options and international market expansion mechanisms. Deloitte’s regional and global network can play a key role in structuring financial models for scaling our digital lab solutions.

  • Neophytos PAREAS (Envision Strategy): As Head of Financial Strategy at Envision, Mr. Pareas opened the door for collaboration in strategic investment planning and potential partnerships with innovation-driven enterprises across Europe and the Middle East.

 

These engagements reinforced our commitment to building sustainable, cross-sector partnerships that amplify the reach of the VITALE software and automation platforms. Each conversation not only laid groundwork for tangible next steps but also validated our core mission: to redefine how laboratories operate through intelligence, modularity, and openness.


Valuable Feedback: Strengthening Bonds and Expanding Horizons

Dr. Kyriakou's participation at the forum reflects EFEVRE TECH’s commitment to innovation and global connectivity. The event highlighted the importance of the Cypriot diaspora’s role in shaping the future of science and technology through partnerships and knowledge exchange. As Dr. Kyriakou concluded his presentation, it was clear that VITALE had sparked the interest of many, reaffirming EFEVRE TECH’s leadership in the digital transformation of scientific research.

​The Cyprus Diaspora Forum continues to be a landmark event that bridges the gap between local innovation and global opportunities, and EFEVRE TECH’s presence showcased the company’s commitment to pioneering advancements in the scientific community.


Looking Ahead: Building Scientific Trust, One Connection at a Time

Following Cyprus DIASPORA 2024, EFEVRE TECH is entering the final stages of VITALE’s pilot development program, building on the momentum created through this landmark event. With new collaborative opportunities underway and an expanding network, VITALE is positioned to become a cornerstone of next-generation laboratory automation and research reliability.

Stay tuned as we continue building VITALE—an intelligent foundation for the future of research!


​​​​The Project with the proposal number ENTERPRISES/0223/Sub-Call1/105 and project acronym VITALE is funded by the European Union Recovery and Resilience Facility of the NextGenerationEU instrument, through the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation.

Project Funded by the European Union


 
 
 

Comments


Stay Connected!

  • LinkedIn
  • Youtube
  • Facebook
  • X

© All Rights Reserved 2035

bottom of page